First patients enrolled for Priothera’s mocravimod trial
Treatment is a maintenance therapy for certain patients with acute myeloid leukaemia
Read More
Tag: priothera
Priothera reveals positive mocravimod data
Therapy is well-tolerated in allogeneic haematopoietic cell transplantation (HCT) patients
Read More
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
- Daratumumab becomes first oncology injectable approved for patient administration
- Laigo Bio completes final close of €17m seed financing round
